AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
AstronauTx has raised $58.7M in total funding. The most recent round was Series A. The last funding was announced in October 2023.
AstronauTx's investors include Dementia Discovery Fund, Bristol-Myers Squibb, Innovate UK, EQT Life Sciences, MPM Capital.
AstronauTx is headquartered in Reading, United Kingdom.
AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
AstronauTx is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AstronauTx — Funding & Investors." VCBacked, October 8, 2023, https://www.vcbacked.co/company/astronautx. Accessed August 13, 2026.
VCBacked. (2023). AstronauTx — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/astronautx
{{cite web |title=AstronauTx — Funding & Investors |url=https://www.vcbacked.co/company/astronautx |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated